Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
John Gunstad, David Disabato, Roman Shrestha, Victoria Sanborn, Colleen B. Mistler & Michael M. Copenhaver. (2023) Latent profile analysis of data from the brief inventory of neurocognitive impairment (BINI) to develop neuro-cognitive profiles among opioid-dependent patients in drug treatment. Journal of Addictive Diseases 41:2, pages 120-127.
Read now
Read now
Michael M. Copenhaver, Victoria Sanborn, Roman Shrestha, Colleen Mistler & John Gunstad. (2021) Association between the brief inventory of neurocognitive impairment (BINI) and objective cognitive testing among persons with opioid use disorders in drug treatment. Journal of Addictive Diseases 39:2, pages 166-174.
Read now
Read now
Damian Weikum, Roman Shrestha, Enrico G. Ferro, Panagiotis Vagenas, Michael Copenhaver, Serena Spudich, Michael D. Alpert, Robinson Cabello, Javier R. Lama, Jorge Sanchez & Frederick L. Altice. (2017) An explanatory factor analysis of a brief self-report scale to detect neurocognitive impairment among HIV-positive men who have sex with men and transgender women in Peru. AIDS Care 29:10, pages 1297-1301.
Read now
Read now
Timothy J. Arentsen, Stella Panos, April D. Thames, J. Natalie Arbid, Steven A. Castellon & Charles H. Hinkin. (2016) Psychosocial correlates of medication adherence among HIV-positive, cognitively impaired individuals. Journal of HIV/AIDS & Social Services 15:4, pages 404-416.
Read now
Read now
Enrico G. Ferro, Damian Weikum, Panagiotis Vagenas, Michael M. Copenhaver, Pedro Gonzales, Jesus Peinado, Robinson Cabello, Javier R. Lama, Jorge Sanchez & Frederick L. Altice. (2015) Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru. AIDS Care 27:1, pages 93-104.
Read now
Read now
Articles from other publishers (20)
Birhanie Mekuriaw, Zelalem Belayneh, Worku Teshome & Yonas Akalu. (2023) Prevalence and variability of HIV/AIDS-associated neurocognitive impairments in Africa: a systematic review and meta-analysis. BMC Public Health 23:1.
Crossref
Crossref
Colleen B. Mistler, Christie I. Idiong & Michael M. Copenhaver. (2022) Integrating Cognitive Dysfunction Accommodation Strategies Into Behavioral Interventions for Persons on Medication for Opioid Use Disorder. Frontiers in Public Health 10.
Crossref
Crossref
Michael Voronkov, Janna Ataiants, Benjamin Cocchiaro, Jeffry B Stock & Stephen E Lankenau. (2021) A vicious cycle of neuropathological, cognitive and behavioural sequelae of repeated opioid overdose. International Journal of Drug Policy 97, pages 103362.
Crossref
Crossref
Colleen B Mistler, Roman Shrestha, John Gunstad, Victoria Sanborn & Michael M Copenhaver. (2021) Adapting behavioural interventions to compensate for cognitive dysfunction in persons with opioid use disorder. General Psychiatry 34:4, pages e100412.
Crossref
Crossref
Thomas L. Patterson, Eileen V. Pitpitan, Heather A. Pines, Shirley J. Semple, Alicia Harvey-Vera, Colin Depp, David J. Moore, Gustavo Martinez, M. Gudelia Rangel & Steffanie A. Strathdee. (2020) A Randomized Controlled Trial of a Texting Intervention to Maintain Sexual Risk Reduction with Clients Among Female Sex Workers in Tijuana and Ciudad Juarez, Mexico. AIDS and Behavior 24:12, pages 3306-3319.
Crossref
Crossref
Roman Shrestha, Pramila Karki & Michael Copenhaver. 2020. The Wiley Handbook of Healthcare Treatment Engagement. The Wiley Handbook of Healthcare Treatment Engagement
109
140
.
Roman Shrestha, Frederick L. Altice, Brian Sibilio, Jude Ssenyonjo & Michael M. Copenhaver. (2019) Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study. Contemporary Clinical Trials 82, pages 77-84.
Crossref
Crossref
Linlin Lindayani, Anastasia Anna & Nai-Ying Ko. (2018) NEUROCOGNITIVE IMPAIRMENT IN HIV/AIDS: A CONCEPTUAL FRAMEWORK. Belitung Nursing Journal 4:5, pages 428-436.
Crossref
Crossref
Roman Shrestha, Tania B. Huedo-Medina, Frederick L. Altice, Archana Krishnan & Michael Copenhaver. (2016) Examining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment. AIDS and Behavior 21:11, pages 3100-3110.
Crossref
Crossref
Roman Shrestha, Damian Weikum, Michael Copenhaver & Frederick L. Altice. (2017) A Self-report Measure to Detect Neurocognitive Impairment Among Incarcerated People Living with HIV in Malaysian Context: an Exploratory Factor Analysis. International Journal of Mental Health and Addiction 15:4, pages 812-825.
Crossref
Crossref
Roman Shrestha, Pramila Karki, Tania B. Huedo-Medina & Michael Copenhaver. (2017) Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis. Journal of the Association of Nurses in AIDS Care 28:4, pages 612-621.
Crossref
Crossref
Roman Shrestha, Frederick AlticeAlticeAltice, Pramila Karki & Michael Copenhaver. (2017) Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research. Frontiers in Immunology 8.
Crossref
Crossref
Roman Shrestha, Frederick L. Altice, Tania B. Huedo-Medina, Pramila Karki & Michael Copenhaver. (2016) Willingness to Use Pre-Exposure Prophylaxis (PrEP): An Empirical Test of the Information-Motivation-Behavioral Skills (IMB) Model among High-Risk Drug Users in Treatment. AIDS and Behavior 21:5, pages 1299-1308.
Crossref
Crossref
Roman Shrestha, Pramila Karki, Tania B. Huedo-Medina & Michael Copenhaver. (2017) Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment. Journal of the Association of Nurses in AIDS Care 28:1, pages 85-94.
Crossref
Crossref
Tania B. Huedo-Medina, Roman Shrestha & Michael Copenhaver. (2016) Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment. AIDS and Behavior 20:8, pages 1646-1657.
Crossref
Crossref
Michael Copenhaver, Roman Shrestha, Jeffrey A. Wickersham, Damian Weikum & Frederick L. Altice. (2016) An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy. Journal of Substance Abuse Treatment 63, pages 61-65.
Crossref
Crossref
Roman Shrestha & Michael Copenhaver. (2016) The Influence of Neurocognitive Impairment on HIV Risk Behaviors and Intervention Outcomes among High-Risk Substance Users: A Systematic Review. Frontiers in Public Health 4.
Crossref
Crossref
Roman ShresthaTania B. Huedo-MedinaMichael M. Copenhaver. (2015) Sex-Related Differences in Self-Reported Neurocognitive Impairment among High-Risk Cocaine Users in Methadone Maintenance Treatment Program. Substance Abuse: Research and Treatment 9, pages SART.S23332.
Crossref
Crossref
Adrienne J. Heinz, Kethera A. Fogler, Michael E. Newcomb, Jodie A. Trafton & Marcel O. Bonn-Miller. (2013) Problematic Alcohol Use Among Individuals with HIV: Relations with Everyday Memory Functioning and HIV Symptom Severity. AIDS and Behavior 18:7, pages 1302-1314.
Crossref
Crossref
Brian Giunta, William Hervey, Cory Klippel, Demian Obregon, Derek Robben, Kimberly Hartney, Barbara Lubrano di Ciccone & Francisco Fernandez. (2013) Psychiatric Complications of HIV Infection: An Overview. Psychiatric Annals 43:5, pages 199-203.
Crossref
Crossref